An integrative approach to disease gene discovery combining genetic variation, gene expression, and epigenetics.

结合遗传变异、基因表达和表观遗传学的疾病基因发现的综合方法。

基本信息

  • 批准号:
    10581608
  • 负责人:
  • 金额:
    $ 15.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-01 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY ABSTRACT Genome-wide association studies (GWASs) have uncovered hundreds of thousands of disease-associated genetic variations, but a remarkable disconnect persists between GWAS findings and biological insight required for clinical treatments and medicine advancement. Pinpointing the functional consequences of variants found in GWASs is complicated by linkage disequilibrium (LD) and the inability to interpret non-coding variations. Systematic genetic analysis of high-dimensional molecular and cellular datasets such as transcriptomics, epigenomics, proteomics, and metabolomics, offers the potential to bridge the gap from complex trait association to relevant biological processes yet poses unsolved computational and analytical challenges. The candidate proposes to address major gaps in existing methodologies for mapping the genetic basis of molecular phenotypes and integrating multi-omics data to improve disease gene discovery by developing a suite of open-source statistical methods and publicly available analytical resources. The candidate will: 1) develop a novel scalable statistical method to detect genome-wide expression quantitative trait loci (eQTL) using large- scale bulk or single-cell RNA sequencing (scRNA-seq) data with an extension for rare variants; 2) assemble and analyze more than 24 readily available bulk and scRNA-seq data sets for a comprehensive repository containing cis- and trans-eQTLs of both common and rare variations; 3) develop an integrative method to improve power for disease gene discovery by combining epigenetics, genome-wide eQTLs, and genetic variations. The proposed research and training plan were carefully designed to confer expertise in four domains: 1) transcriptomics and epigenomics, 2) statistical methods development, 3) large-scale data analysis and tools, and 4) professional development. These skills are fundamental to the candidate’s goal of becoming a leading investigator who develops and applies statistical methods to understand molecular mechanisms of complex diseases and traits. In addition to research training, the candidate will take coursework to gain greater expertise in transcriptomics and functional genomics, participate in regular seminars, attend workshops and conferences, and gain mentorship and teaching experience. All research will be conducted in the Analytic and Translational Genetics Unit at Massachusetts General Hospital and the Broad Institute with mentorship from renowned scientists Drs. Benjamin Neale and Mark Daly. Additional guidance from leading experts Drs. Xihong Lin, Ramnik Xavier, Kristin Ardlie, and Bradley Bernstein will ensure exceptional guidance and support. Overall, the training environment is outstanding, the mentors and advisors are world-class, the proposed studies address an urgent unmet need, and the additional skills gained in this award will poise the candidate to establish independent leadership in leveraging statistical genetics and large-scale multi-omics data for disentangling the etiology of complex diseases.
项目摘要 全基因组关联研究(GWAS)已经发现了数十万种与疾病相关的基因。 遗传变异,但GWAS的发现和所需的生物学洞察力之间存在显着的脱节 用于临床治疗和医学发展。精确定位发现的变异的功能后果, GWAS因连锁不平衡(LD)和无法解释非编码变异而变得复杂。 对高维分子和细胞数据集(如转录组学)进行系统遗传分析, 表观基因组学、蛋白质组学和代谢组学的出现,为弥合复杂性状关联的差距提供了可能 相关的生物过程,但提出了未解决的计算和分析的挑战。 候选人提议解决现有方法中的主要差距,以绘制遗传基础, 分子表型和整合多组学数据,通过开发一套 开源统计方法和公开可用的分析资源。候选人将:1)开发一个 一种新的可扩展的统计方法来检测全基因组表达的数量性状基因座(eQTL),使用大 大规模批量或单细胞RNA测序(scRNA-seq)数据,具有罕见变体的延伸; 2)组装和 分析超过24个现成的批量和scRNA-seq数据集,用于全面的存储库, 常见变异和罕见变异的顺式和反式eQTL; 3)开发一种综合方法来提高功率 通过结合表观遗传学、全基因组eQTL和遗传变异来发现疾病基因。 拟议的研究和培训计划是精心设计的,旨在提供四个领域的专业知识: 转录组学和表观基因组学,2)统计方法开发,3)大规模数据分析和工具, (4)专业发展。这些技能是候选人成为领导者的基本目标 发展和应用统计学方法来理解复杂的分子机制的研究者 疾病和特征。除了研究培训,候选人将参加课程,以获得更大的专业知识 在转录组学和功能基因组学方面,参加定期研讨会、讲习班和会议, 并获得指导和教学经验。所有研究将在分析和翻译 马萨诸塞州总医院和布罗德研究所的遗传学部门, 科学家本杰明·尼尔和马克·戴利博士来自领先专家林希宏博士的额外指导,Ramnik Xavier、Kristin Ardlie和布拉德利伯恩斯坦将确保提供卓越的指导和支持。总的来说,培训 环境是杰出的,导师和顾问是世界一流的,拟议的研究解决了一个紧迫的问题, 未满足的需求,以及在此奖项中获得的额外技能将使候选人能够建立独立的 在利用统计遗传学和大规模多组学数据解开病因学方面的领导地位 复杂的疾病。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wei Zhou其他文献

Spin Waves Excitations of Co/PtMultilayers
Co/Pt 多层膜的自旋波激发

Wei Zhou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wei Zhou', 18)}}的其他基金

Targeting LKB1-null lung adenocarcinoma with innate immune system
利用先天免疫系统靶向 LKB1 缺失的肺腺癌
  • 批准号:
    10752833
  • 财政年份:
    2023
  • 资助金额:
    $ 15.94万
  • 项目类别:
An integrative approach to disease gene discovery combining genetic variation, gene expression, and epigenetics.
结合遗传变异、基因表达和表观遗传学的疾病基因发现的综合方法。
  • 批准号:
    10349878
  • 财政年份:
    2022
  • 资助金额:
    $ 15.94万
  • 项目类别:
Role of orexin/hypocretin circuit in anesthesia and analgesia
食欲素/下丘脑分泌素回路在麻醉和镇痛中的作用
  • 批准号:
    10651642
  • 财政年份:
    2020
  • 资助金额:
    $ 15.94万
  • 项目类别:
Role of orexin/hypocretin circuit in anesthesia and analgesia
食欲素/下丘脑分泌素回路在麻醉和镇痛中的作用
  • 批准号:
    10186780
  • 财政年份:
    2020
  • 资助金额:
    $ 15.94万
  • 项目类别:
Role of orexin/hypocretin circuit in anesthesia and analgesia
食欲素/下丘脑分泌素回路在麻醉和镇痛中的作用
  • 批准号:
    10430182
  • 财政年份:
    2020
  • 资助金额:
    $ 15.94万
  • 项目类别:
Role of orexin/hypocretin circuit in anesthesia and analgesia
食欲素/下丘脑分泌素回路在麻醉和镇痛中的作用
  • 批准号:
    10040369
  • 财政年份:
    2020
  • 资助金额:
    $ 15.94万
  • 项目类别:
PKC Epsilon in Vascular Dysfunction
PKC Epsilon 在血管功能障碍中的应用
  • 批准号:
    8329950
  • 财政年份:
    2012
  • 资助金额:
    $ 15.94万
  • 项目类别:
PKC Epsilon in Vascular Dysfunction
PKC Epsilon 在血管功能障碍中的应用
  • 批准号:
    8536078
  • 财政年份:
    2012
  • 资助金额:
    $ 15.94万
  • 项目类别:
PKC Epsilon in Vascular Dysfunction
PKC Epsilon 在血管功能障碍中的应用
  • 批准号:
    8698299
  • 财政年份:
    2012
  • 资助金额:
    $ 15.94万
  • 项目类别:
Pro-Oncogenic Role of LKB1 in NSCLC
LKB1 在 NSCLC 中的促癌作用
  • 批准号:
    8830435
  • 财政年份:
    2011
  • 资助金额:
    $ 15.94万
  • 项目类别:

相似海外基金

I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
  • 批准号:
    10102692
  • 财政年份:
    2024
  • 资助金额:
    $ 15.94万
  • 项目类别:
    EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
  • 批准号:
    10639785
  • 财政年份:
    2023
  • 资助金额:
    $ 15.94万
  • 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
  • 批准号:
    23K09052
  • 财政年份:
    2023
  • 资助金额:
    $ 15.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 15.94万
  • 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
  • 批准号:
    10642988
  • 财政年份:
    2023
  • 资助金额:
    $ 15.94万
  • 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    $ 15.94万
  • 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
  • 批准号:
    10584110
  • 财政年份:
    2023
  • 资助金额:
    $ 15.94万
  • 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
  • 批准号:
    22H03243
  • 财政年份:
    2022
  • 资助金额:
    $ 15.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
  • 批准号:
    10433610
  • 财政年份:
    2022
  • 资助金额:
    $ 15.94万
  • 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
  • 批准号:
    10504138
  • 财政年份:
    2022
  • 资助金额:
    $ 15.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了